CB Rank (Person) 1,644,044

Simon Robinson has served as our Vice President Research and Pharmaceutical Development since 2010. He has held positions of increasing responsibility with the company for imaging agent discovery for more than 10 years. Dr. Robinson has more than 20 years of industrial experience in molecular targeted small molecule development with research

positions at Bristol Myers Squibb, Sphinx Pharmaceuticals, BASF and Dupont Pharmaceuticals. He has a Ph.D. and B.Sc. in Pharmacology from the University of Leeds, England and did post-doctoral training at the University of Wisconsin Clinical Cancer Center.

Number of News Articles 32
NewsJun 9, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsDec 1, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsSep 4, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsAug 9, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsAug 9, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJul 19, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJul 12, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJul 12, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJun 14, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsJun 13, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated